Dr. Sunitha Vemulapalli
Claim this profileAultman Health Foundation
Studies Breast Cancer
Studies Lung Cancer
25 reported clinical trials
76 drugs studied
About Sunitha Vemulapalli
Education:
- Earned a Medical Degree (MD), with the specific institution not mentioned.
Experience:
- Specializes in breast cancer care at Aultman Health Foundation.
- Boasts over 20 years of experience in breast cancer patient care.
- Integral part of the multidisciplinary team at Aultman's Breast Care Center, recognized as a "Center of Excellence" by the American College of Radiology and fully accredited by the National Accreditation Program for Breast Centers.
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage II
2Lung Cancer
Stage IV
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Sunitha Vemulapalli is currently running
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Sunitha Vemulapalli
Clinical Trial Related6 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Sunitha Vemulapalli has experience with
- Paclitaxel
- Ipatasertib
- Binimetinib
- Fulvestrant
- Biospecimen Collection
- Pembrolizumab
Breakdown of trials Sunitha Vemulapalli has run
Breast Cancer
Lung Cancer
Breast cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sunitha Vemulapalli specialize in?
Sunitha Vemulapalli focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Sunitha Vemulapalli currently recruiting for clinical trials?
Yes, Sunitha Vemulapalli is currently recruiting for 10 clinical trials in Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Sunitha Vemulapalli has studied deeply?
Yes, Sunitha Vemulapalli has studied treatments such as Paclitaxel, Ipatasertib, Binimetinib.
What is the best way to schedule an appointment with Sunitha Vemulapalli?
Apply for one of the trials that Sunitha Vemulapalli is conducting.
What is the office address of Sunitha Vemulapalli?
The office of Sunitha Vemulapalli is located at: Aultman Health Foundation, Canton, Ohio 44710 United States. This is the address for their practice at the Aultman Health Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.